Pallister-Hall Syndrome

🏷

Classifications

ISDS Skeletal Nosology

👪

Inheritance

1

Autosomal Dominant

Autosomal dominant with variable expressivity. Unlike GCPS which results from GLI3 haploinsufficiency, PHS is caused specifically by frameshift/nonsense mutations in the middle third of GLI3 that produce a truncated constitutive repressor protein.

Show evidence (1 reference)

PMID:15739154 SUPPORT

"GLI3 mutations that predict a truncated functional repressor protein cause PHS and that functional haploinsufficiency of GLI3 causes GCPS"

Distinct pathogenic mechanism from GCPS: constitutive repressor rather than haploinsufficiency.

?

Discussions and Knowledge Gaps

1

Should congenital hypothalamic hamartoma syndrome (MONDO:0009436), which MONDO files as the sole is_a child of this entry's term and attributes to SMO, be curated as a subtype of Pallister-Hall syndrome?

KNOWLEDGE GAP OPEN phs_scope_sporadic_hypothalamic_hamartoma

Attached to

pathophysiology#Hypothalamic Development Disruption

This entry declines that placement, and MONDO:0009436's own textual definition is the reason. That definition closes "Though hypothalamic hamartomas can occur in patients with certain genetic disorders (such as Pallister-Hall syndrome), the majority of cases are sporadic", and its synonyms are the bare lesion names - hypothalamic hamartoma, hamartoma of the hypothalamus - plus "Pallister-Hall-like syndrome". So the concept MONDO describes there is predominantly sporadic hypothalamic hamartoma, of which germline Pallister-Hall syndrome is one minority cause. Placing it beneath this entry inverts that relationship, and through this term it inherits hereditary disease, polydactyly, syndactyly, skeletal dysplasia and pituitary deficiency, none of which the definition claims for the sporadic majority. The causal gene MONDO records for it is also not this entry's gene. Its OWL axioms assert SMO (hgnc:11119), whereas Pallister-Hall syndrome is a germline GLI3 disorder. In sporadic hypothalamic hamartoma, SMO has been implicated only as one of several Shh-pathway genes falling inside brain-tissue-specific large copy-number or loss-of-heterozygosity lesions, rather than as an individually recurrent somatic target; the recurrent somatic genes in that series were PRKACA and GLI3. The sporadic, somatically driven entity is curated in this repository as Hypothalamic Hamartoma with Gelastic Seizures, bound to MONDO:0019484, whose own node for the initiating lesion is a somatic Sonic hedgehog pathway mutation. That is where an SMO assertion belongs, and that entry currently names SMO in prose without a bound genetic record, which is the open piece of work here.

Recording rather than silently resolving this, because a future curator following MONDO's hierarchy will find it asserting a parentage this entry declines. The same shape - MONDO's is_a placement disagreeing with MONDO's own definition of the same term - is recorded on the Hemophilia entry for factor XI deficiency.

⚙

Pathophysiology

4

GLI3 Constitutive Repressor from Truncating Mutations

Truncating mutations in the middle third of GLI3 (ORF nt 1998-3481) produce a protein that retains the N-terminal zinc finger DNA-binding domain and repressor domain but lacks the C-terminal transactivation domain. This truncated protein functions as a constitutive repressor of Hedgehog target genes, independent of Hedgehog signaling input.

GLI3 hgnc:4319

Genetic context GLI3 hgnc:4319 variant_origin: GERMLINE zygosity: HETEROZYGOUS

Heterozygous frameshift, nonsense and splicing variants in the middle third of the GLI3 ORF yield a C-terminally truncated protein. No `functional_impact_category` is recorded: the cited sources establish the variant classes and their positional correlation with phenotype, but none of them labels the mechanism as dominant-negative, neomorphic or gain-of-function, and this entry's contrast with GCPS haploinsufficiency is argued from the node evidence rather than from such a label.

Hedgehog Signaling Pathway GO:0007224

Downstream

Hypothalamic Development Disruption Inappropriate repression of Hedgehog target genes in the developing ventral hypothalamus is the step this entry models between the truncated GLI3 protein and hamartoma formation.

Posterior Limb Patterning Disruption The same constitutive repressor acts on Hedgehog-dependent anterior-posterior limb patterning, where GLI3 repressor is the principal output of the pathway.

Bifid Epiglottis Bifid epiglottis is the mildest of the midline airway malformations attributed to the GLI3 lesion. This entry does not model the intervening laryngeal developmental program, because none of its sources states one.

Laryngeal Cleft Laryngotracheal cleft sits at the severe end of the same midline airway spectrum and is the lesion responsible for neonatal lethality. The intervening developmental program is not modelled here.

Anal Atresia Anal atresia or stenosis is the hindgut midline malformation of the syndrome. As with the airway defects, no source cited here states the developmental step between the GLI3 lesion and the malformation.

Show evidence (5 references)

PMID:15739154 SUPPORT

"In contrast, PHS was caused only by frameshift/nonsense and splicing mutations"

Only truncating mutations cause PHS, supporting the constitutive repressor model.

PMID:15739154 SUPPORT

"among the frameshift/nonsense mutations, there was a clear genotype-phenotype correlation"

Positional specificity of truncating mutations determines GCPS vs PHS phenotype.

PMID:10375510 SUPPORT Model Organism

"C-terminal sequences are required for positive inducing activity"

Loss of C-terminal transactivation domain explains why middle-third truncations produce a constitutive repressor.

+ 2 more references

Hypothalamic Development Disruption

Constitutive GLI3 repressor activity inappropriately silences Hedgehog target genes required for hypothalamic development, leading to hypothalamic hamartoma formation. This can cause precocious puberty through ectopic GnRH secretion or gelastic seizures.

GLI3 hgnc:4319

Downstream

Hypothalamic-Pituitary Axis Disruption Hypothalamic hamartoma formation disrupts pituitary signaling, leading to endocrine insufficiency including adrenal insufficiency.

Hypothalamic Hamartoma Failure of normal ventral hypothalamic development yields the non-neoplastic hamartoma that is the cardinal feature of the syndrome.

Show evidence (2 references)

PMID:10375510 SUPPORT Model Organism

"provide a molecular basis for the human Polydactyly type A and Pallister-Hall Syndrome phenotypes, derived from the deregulated production of C-terminally truncated GLI3 proteins"

Truncated GLI3 repressor disrupts multiple developmental programs including hypothalamic development.

PMID:20301638 SUPPORT Human Clinical

"Individuals with GLI3-PHS can have pituitary insufficiency and may die as neonates from undiagnosed and untreated adrenal insufficiency."

Hypothalamic hamartoma disrupts hypothalamic-pituitary signaling, causing pituitary insufficiency and potentially fatal adrenal insufficiency.

Posterior Limb Patterning Disruption

Constitutive GLI3 repressor activity disrupts Hedgehog-dependent limb patterning, causing postaxial or central polydactyly. This is distinct from the preaxial polydactyly seen in GCPS, where GLI3 haploinsufficiency (reduced activator) rather than constitutive repressor drives the phenotype.

GLI3 hgnc:4319

Embryonic Limb Morphogenesis GO:0030326

Downstream

Postaxial Polydactyly Disrupted anterior-posterior patterning of the limb bud produces the postaxial or mesoaxial extra digits of this syndrome.

Show evidence (1 reference)

PMID:10375510 SUPPORT Model Organism

"provide a molecular basis for the human Polydactyly type A and Pallister-Hall Syndrome phenotypes, derived from the deregulated production of C-terminally truncated GLI3 proteins"

Truncated GLI3 directly causes the polydactyly phenotype in PHS.

Hypothalamic-Pituitary Axis Disruption

The hypothalamic hamartoma disrupts normal hypothalamic-pituitary axis signaling, producing a spectrum of endocrine insufficiency ranging from isolated growth hormone deficiency to panhypopituitarism. Adrenal insufficiency (secondary to ACTH deficiency) is a potentially lethal complication in neonates and infants that requires urgent evaluation and cortisol replacement before or alongside other endocrine workup. Precocious puberty may result from ectopic GnRH secretion by the hamartoma.

Pituitary gland development GO:0021983

Downstream

Hypopituitarism Loss of normal hypothalamic input to the pituitary produces a spectrum of anterior pituitary hormone deficiency.

Adrenal Insufficiency ACTH deficiency within that pituitary insufficiency causes secondary adrenal insufficiency, the potentially lethal neonatal complication.

Show evidence (1 reference)

PMID:20301638 SUPPORT Human Clinical

"Individuals with GLI3-PHS can have pituitary insufficiency and may die as neonates from undiagnosed and untreated adrenal insufficiency."

GeneReviews explicitly documents pituitary insufficiency as a complication and adrenal crisis as a potentially lethal outcome in untreated neonates.

⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.

●

Phenotypes

9

Digestive 1

Anal Atresia HP:0002023

Show evidence (1 reference)

PMID:24736735 SUPPORT

"hypothalamic hamartoma, postaxial or central polydactyly, anal atresia and bifid epiglottis"

Anal atresia is a cardinal feature of PHS.

Endocrine 3

Central Precocious Puberty HP:0000826

Show evidence (1 reference)

PMID:20301638 SUPPORT Human Clinical

"monitor for signs of precocious puberty"

GeneReviews surveillance guidelines specify annual monitoring for precocious puberty as a complication of hypothalamic hamartoma in GLI3-PHS.

Hypopituitarism HP:0040075

Show evidence (1 reference)

PMID:20301638 SUPPORT Human Clinical

"Individuals with GLI3-PHS can have pituitary insufficiency and may die as neonates from undiagnosed and untreated adrenal insufficiency."

GeneReviews identifies pituitary insufficiency as an important complication of GLI3-PHS that can be lethal if adrenal axis involvement is missed.

Adrenal Insufficiency HP:0000846

Show evidence (1 reference)

PMID:20301638 SUPPORT Human Clinical

"Individuals with GLI3-PHS can have pituitary insufficiency and may die as neonates from undiagnosed and untreated adrenal insufficiency."

GeneReviews documents adrenal insufficiency as a potentially lethal complication requiring urgent evaluation and treatment.

Limbs 1

Postaxial Polydactyly Postaxial hand polydactyly HP:0001162

Show evidence (2 references)

PMID:24736735 SUPPORT

"postaxial or central polydactyly, anal atresia and bifid epiglottis"

Postaxial/central polydactyly is the characteristic limb pattern in PHS.

PMID:28224613 SUPPORT

"four separate entities; each characterized by a specific pattern of polydactyly"

PHS has a distinct polydactyly pattern (postaxial) from GCPS (preaxial).

Nervous System 1

Gelastic Seizures Focal emotional seizure with laughing HP:0010821

Show evidence (2 references)

PMID:12773293 SUPPORT Human Clinical

"who suffered from drug resistant laughing seizures since childhood"

Case report of a PHS patient (postaxial polydactyly + hypothalamic hamartoma) who presented with laughing seizures (gelastic seizures) since childhood, directly linking this seizure type to PHS.

PMID:20301638 SUPPORT Human Clinical

"symptomatic treatment of seizures"

GeneReviews lists seizures as a key manifestation requiring symptomatic treatment in GLI3-PHS, associated with hypothalamic hamartoma.

Respiratory 2

Bifid Epiglottis HP:0010564

Show evidence (1 reference)

PMID:24736735 SUPPORT

"hypothalamic hamartoma, postaxial or central polydactyly, anal atresia and bifid epiglottis"

Bifid epiglottis is one of the cardinal features in the original PHS description.

Laryngeal Cleft HP:0008751

Show evidence (1 reference)

PMID:20301638 SUPPORT Human Clinical

"laryngotracheal cleft with neonatal lethality at the severe end"

GeneReviews defines the clinical spectrum of GLI3-PHS from mild (polydactyly, bifid epiglottis) to lethal (laryngotracheal cleft).

Neoplasm 1

Hypothalamic Hamartoma HP:0002444

Sequelae: Gelastic Seizures Central Precocious Puberty

Show evidence (1 reference)

PMID:24736735 SUPPORT

"PHS was first described as a lethal condition associating hypothalamic hamartoma, postaxial or central polydactyly, anal atresia and bifid epiglottis"

Hypothalamic hamartoma is a cardinal feature of PHS since original description.

🧬

Genetic Associations

1

GLI3 Mutations (Truncating, Middle Third) (Causative)

Gene: GLI3 hgnc:4319 gene page relationship_type: CAUSATIVE variant_origin: GERMLINE

Show evidence (5 references)

PMID:15739154 SUPPORT

"Mutations in the GLI3 zinc-finger transcription factor gene cause Greig cephalopolysyndactyly syndrome (GCPS) and Pallister-Hall syndrome (PHS), which are variable but distinct clinical entities"

Establishes GLI3 as causative for both GCPS and PHS as allelic disorders.

PMID:15739154 SUPPORT

"These results demonstrate a robust correlation of genotype and phenotype for GLI3 mutations and strongly support the hypothesis that these two allelic disorders have distinct modes of pathogenesis"

Robust genotype-phenotype correlation across 135-patient cohort.

PMID:20672375 SUPPORT

"A range of phenotypes including Greig cephalopolysyndactyly and Pallister-Hall syndromes (GCPS, PHS) are caused by pathogenic mutation of the GLI3 gene"

Expanded cohort confirms GLI3 as the causative gene for PHS.

+ 2 more references

💊

Medical Actions

5

Surgical Correction of Polydactyly

Action: surgical procedure Ontology label: Surgical Procedure NCIT:C15329

Located in: manus UBERON:0002398

Platform: Surgery

Surgical removal of extra digits in early childhood for functional and cosmetic improvement.

Anal Atresia Repair

Neonatal surgical correction of imperforate anus, typically posterior sagittal anorectoplasty (PSARP).

Endocrine Management

Action: endocrine hormone replacement and management Ontology label: Hormone Replacement Therapy NCIT:C15599

Adrenal insufficiency is the first priority: cortisol deficiency must be evaluated urgently in all newly diagnosed patients, especially neonates, as untreated adrenal crisis can be fatal. Annual surveillance during childhood includes growth assessment (for growth hormone deficiency) and monitoring for signs of precocious puberty. GnRH analogs may be used if central precocious puberty develops. Pituitary function testing should be performed at baseline in all patients.

Show evidence (1 reference)

PMID:20301638 SUPPORT Human Clinical

"Urgent treatment for endocrine abnormalities, especially cortisol deficiency"

GeneReviews prioritizes cortisol deficiency treatment above other endocrine management, emphasizing the lethal risk of undiagnosed adrenal insufficiency.

Anti-Seizure Medication

Action: Anticonvulsant Therapy NCIT:C64172

Symptomatic treatment for seizures associated with hypothalamic hamartoma, using standard anti-seizure medications. Stimulants prescribed for ADHD may exacerbate seizures and should be used with caution or avoided.

Show evidence (1 reference)

PMID:20301638 SUPPORT Human Clinical

"symptomatic treatment of seizures"

GeneReviews lists symptomatic seizure treatment as a key management step and notes that stimulants may exacerbate seizures in GLI3-PHS.

Hypothalamic Hamartoma — Watchful Waiting

Action: supportive care Ontology label: Supportive Care NCIT:C15747

Hypothalamic hamartomas in PHS are malformations, not neoplasms; they grow at the same rate as surrounding brain tissue. Biopsy or surgical resection is generally contraindicated because complications and the resulting need for lifelong hormone replacement typically outweigh any potential benefit. Management focuses on endocrine replacement and anti-seizure therapy rather than surgical intervention.

Show evidence (1 reference)

PMID:20301638 SUPPORT Human Clinical

"Biopsy or resection of hypothalamic hamartoma may result in complications and lifelong need for hormone replacement."

GeneReviews explicitly states that hamartoma biopsy or resection is to be avoided in typical presentations of GLI3-PHS.

🔬

Diagnosis

1

Clinical and Molecular Diagnosis

GLI3-related Pallister-Hall syndrome is diagnosed clinically from the combination of hypothalamic hamartoma and mesoaxial (central) polydactyly, and is confirmed by identification of a heterozygous GLI3 pathogenic variant on molecular genetic testing. Recognition matters because hypothalamic hamartoma may cause hypopituitarism or gelastic seizures.

molecular genetic testing NCIT:C19770

Show evidence (1 reference)

PMID:20301638 SUPPORT Human Clinical

"The diagnosis of GLI3-PHS can be established in a proband with both hypothalamic hamartoma and mesoaxial polydactyly."

GeneReviews defines the cardinal clinical diagnostic dyad for GLI3-related Pallister-Hall syndrome.

📊

Prevalence

1

GLI3 mutation-positive GCPS/PHS diagnostic cohort

27.6%

Population prevalence for Pallister-Hall syndrome is not well defined, but a large GLI3 cohort reported 21 PHS cases among 76 total GLI3 syndrome cases.

Show evidence (2 references)

PMID:24736735 SUPPORT Human Clinical

"Here we report on the molecular and clinical study of 76 cases from 55 families with either a GLI3 mutation (49 GCPS and 21 PHS), or a large deletion encompassing the GLI3 gene (6 GCPS cases)."

This large GLI3 cohort shows that 21 of 76 mutation-positive GCPS/PHS cases were Pallister-Hall syndrome, corresponding to 27.6%.

PMID:29106787 SUPPORT Human Clinical

"This rare syndrome has not had prevalence defined, however."

This adult case report explicitly notes that population prevalence for Pallister-Hall syndrome has not been defined.

{ }

Source YAML

click to show

name: Pallister-Hall Syndrome
creation_date: '2026-02-13T00:31:42Z'
category: Mendelian
description: >
  Pallister-Hall syndrome (PHS) is an autosomal dominant disorder caused by
  truncating mutations in the middle third of the GLI3 gene. These mutations
  produce a constitutive transcriptional repressor that inappropriately suppresses
  Hedgehog target genes, causing a distinct phenotype from the allelic disorder
  Greig cephalopolysyndactyly syndrome. PHS is characterized by hypothalamic
  hamartoma, postaxial or central polydactyly, bifid epiglottis, anal atresia,
  and variable other malformations. Severity ranges from lethal neonatal forms
  to mild adult presentations.
disease_term:
  preferred_term: Pallister-Hall syndrome
  term:
    id: MONDO:0007804
    label: Pallister-Hall syndrome
parents:
- Limb Development Disorders
inheritance:
- name: Autosomal Dominant
  description: >
    Autosomal dominant with variable expressivity. Unlike GCPS which
    results from GLI3 haploinsufficiency, PHS is caused specifically by
    frameshift/nonsense mutations in the middle third of GLI3 that
    produce a truncated constitutive repressor protein.
  evidence:
  - reference: PMID:15739154
    reference_title: "Molecular and clinical analyses of Greig cephalopolysyndactyly and Pallister-Hall syndromes: robust phenotype prediction from the type and position of GLI3 mutations."
    supports: SUPPORT
    snippet: "GLI3 mutations that predict a truncated functional repressor protein cause PHS and that functional haploinsufficiency of GLI3 causes GCPS"
    explanation: "Distinct pathogenic mechanism from GCPS: constitutive repressor rather than haploinsufficiency."
classifications:
  isds_skeletal_category:
  - classification_value: polydactyly_syndactyly_triphalangism
    notes: >-
      ISDS Nosology and Classification of Genetic Skeletal Disorders, 2019 revision
      (Mortier et al., PMID:31633310), Table 1 group 41
      "Polydactyly-Syndactyly-Triphalangism group"; listed as "Pallister-Hall syndrome".
prevalence:
- population: GLI3 mutation-positive GCPS/PHS diagnostic cohort
  percentage: 27.6%
  notes: >-
    Population prevalence for Pallister-Hall syndrome is not well defined, but a
    large GLI3 cohort reported 21 PHS cases among 76 total GLI3 syndrome cases.
  evidence:
  - reference: PMID:24736735
    reference_title: "New insights into genotype-phenotype correlation for GLI3 mutations."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Here we report on the molecular and clinical study of 76 cases from 55 families with either a GLI3 mutation (49 GCPS and 21 PHS), or a large deletion encompassing the GLI3 gene (6 GCPS cases)."
    explanation: This large GLI3 cohort shows that 21 of 76 mutation-positive GCPS/PHS cases were Pallister-Hall syndrome, corresponding to 27.6%.
  - reference: PMID:29106787
    reference_title: "Familial Pallister-Hall in adulthood"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "This rare syndrome has not had prevalence defined, however."
    explanation: This adult case report explicitly notes that population prevalence for Pallister-Hall syndrome has not been defined.
pathophysiology:
- name: GLI3 Constitutive Repressor from Truncating Mutations
  description: >
    Truncating mutations in the middle third of GLI3 (ORF nt 1998-3481)
    produce a protein that retains the N-terminal zinc finger DNA-binding
    domain and repressor domain but lacks the C-terminal transactivation
    domain. This truncated protein functions as a constitutive repressor
    of Hedgehog target genes, independent of Hedgehog signaling input.
  genes:
  - preferred_term: GLI3
    term:
      id: hgnc:4319
      label: GLI3
  genetic_context:
    gene:
      preferred_term: GLI3
      term:
        id: hgnc:4319
        label: GLI3
    variant_origin: GERMLINE
    zygosity: HETEROZYGOUS
    description: >-
      Heterozygous frameshift, nonsense and splicing variants in the middle
      third of the GLI3 ORF yield a C-terminally truncated protein. No
      `functional_impact_category` is recorded: the cited sources establish the
      variant classes and their positional correlation with phenotype, but none
      of them labels the mechanism as dominant-negative, neomorphic or
      gain-of-function, and this entry's contrast with GCPS haploinsufficiency
      is argued from the node evidence rather than from such a label.
  biological_processes:
  - preferred_term: Hedgehog Signaling Pathway
    term:
      id: GO:0007224
      label: smoothened signaling pathway
  evidence:
  - reference: PMID:15739154
    reference_title: "Molecular and clinical analyses of Greig cephalopolysyndactyly and Pallister-Hall syndromes: robust phenotype prediction from the type and position of GLI3 mutations."
    supports: SUPPORT
    snippet: "In contrast, PHS was caused only by frameshift/nonsense and splicing mutations"
    explanation: "Only truncating mutations cause PHS, supporting the constitutive repressor model."
  - reference: PMID:15739154
    reference_title: "Molecular and clinical analyses of Greig cephalopolysyndactyly and Pallister-Hall syndromes: robust phenotype prediction from the type and position of GLI3 mutations."
    supports: SUPPORT
    snippet: "among the frameshift/nonsense mutations, there was a clear genotype-phenotype correlation"
    explanation: "Positional specificity of truncating mutations determines GCPS vs PHS phenotype."
  - reference: PMID:10375510
    reference_title: "Gli proteins encode context-dependent positive and negative functions: implications for development and disease."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "C-terminal sequences are required for positive inducing activity"
    explanation: "Loss of C-terminal transactivation domain explains why middle-third truncations produce a constitutive repressor."
  - reference: PMID:20672375
    reference_title: "Molecular analysis expands the spectrum of phenotypes associated with GLI3 mutations."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: BACKGROUND
    snippet: "the truncations in the middle third of the protein are predicted to generate a constitutive repressor protein that skews the balance of activator and repressor forms of GLI3"
    explanation: >-
      States the constitutive-repressor model for middle-third truncations that
      this node asserts, and frames it as a shift in the activator/repressor
      balance rather than as a loss of GLI3 dose.
  - reference: PMID:10693759
    reference_title: "Hedgehog-regulated processing of Gli3 produces an anterior/posterior repressor gradient in the developing vertebrate limb."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "The high relative abundance and potency of Gli3 repressor suggest specialization of Gli3 and its products for negative Hedgehog pathway regulation"
    explanation: "GLI3 is specialized for repressor function, explaining why truncated repressor proteins cause disease."
  downstream:
  - target: Hypothalamic Development Disruption
    description: >-
      Inappropriate repression of Hedgehog target genes in the developing ventral
      hypothalamus is the step this entry models between the truncated GLI3
      protein and hamartoma formation.
    evidence:
    - reference: PMID:10375510
      reference_title: "Gli proteins encode context-dependent positive and negative functions: implications for development and disease."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "provide a molecular basis for the human Polydactyly type A and Pallister-Hall Syndrome phenotypes, derived from the deregulated production of C-terminally truncated GLI3 proteins"
      explanation: >-
        Makes C-terminally truncated GLI3 the molecular basis of the PHS
        developmental phenotypes, which is the step this edge asserts.
  - target: Posterior Limb Patterning Disruption
    description: >-
      The same constitutive repressor acts on Hedgehog-dependent
      anterior-posterior limb patterning, where GLI3 repressor is the principal
      output of the pathway.
    evidence:
    - reference: PMID:10693759
      reference_title: "Hedgehog-regulated processing of Gli3 produces an anterior/posterior repressor gradient in the developing vertebrate limb."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "The high relative abundance and potency of Gli3 repressor suggest specialization of Gli3 and its products for negative Hedgehog pathway regulation"
      explanation: >-
        Establishes GLI3 repressor as the dominant Hedgehog output in the
        developing limb, which is why a constitutive repressor disrupts limb
        patterning.
  - target: Bifid Epiglottis
    description: >-
      Bifid epiglottis is the mildest of the midline airway malformations
      attributed to the GLI3 lesion. This entry does not model the intervening
      laryngeal developmental program, because none of its sources states one.
    evidence:
    - reference: PMID:20301638
      reference_title: "GLI3-Related Pallister-Hall Syndrome."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: REVIEW_SYNTHESIS
      snippet: "GLI3-related Pallister-Hall syndrome (GLI3-PHS) is characterized by a spectrum of anomalies ranging from polydactyly, asymptomatic bifid epiglottis, and hypothalamic hamartoma at the mild end to laryngotracheal cleft with neonatal lethality at the severe end."
      explanation: >-
        Attributes this malformation, along the same severity spectrum, to the
        GLI3 lesion that defines the syndrome.
  - target: Laryngeal Cleft
    description: >-
      Laryngotracheal cleft sits at the severe end of the same midline airway
      spectrum and is the lesion responsible for neonatal lethality. The
      intervening developmental program is not modelled here.
    evidence:
    - reference: PMID:20301638
      reference_title: "GLI3-Related Pallister-Hall Syndrome."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: REVIEW_SYNTHESIS
      snippet: "GLI3-related Pallister-Hall syndrome (GLI3-PHS) is characterized by a spectrum of anomalies ranging from polydactyly, asymptomatic bifid epiglottis, and hypothalamic hamartoma at the mild end to laryngotracheal cleft with neonatal lethality at the severe end."
      explanation: >-
        Attributes this malformation, along the same severity spectrum, to the
        GLI3 lesion that defines the syndrome.
  - target: Anal Atresia
    description: >-
      Anal atresia or stenosis is the hindgut midline malformation of the
      syndrome. As with the airway defects, no source cited here states the
      developmental step between the GLI3 lesion and the malformation.
    evidence:
    - reference: PMID:24736735
      reference_title: "New insights into genotype-phenotype correlation for GLI3 mutations."
      supports: SUPPORT
      snippet: "PHS was first described as a lethal condition associating hypothalamic hamartoma, postaxial or central polydactyly, anal atresia and bifid epiglottis"
      explanation: >-
        Lists anal atresia among the defining anomalies of the GLI3-related
        syndrome.
- name: Hypothalamic Development Disruption
  description: >
    Constitutive GLI3 repressor activity inappropriately silences Hedgehog
    target genes required for hypothalamic development, leading to
    hypothalamic hamartoma formation. This can cause precocious puberty
    through ectopic GnRH secretion or gelastic seizures.
  genes:
  - preferred_term: GLI3
    term:
      id: hgnc:4319
      label: GLI3
  downstream:
  - target: Hypothalamic-Pituitary Axis Disruption
    description: Hypothalamic hamartoma formation disrupts pituitary signaling, leading to endocrine insufficiency including adrenal insufficiency.
  - target: Hypothalamic Hamartoma
    description: >-
      Failure of normal ventral hypothalamic development yields the
      non-neoplastic hamartoma that is the cardinal feature of the syndrome.
    evidence:
    - reference: PMID:24736735
      reference_title: "New insights into genotype-phenotype correlation for GLI3 mutations."
      supports: SUPPORT
      snippet: "PHS was first described as a lethal condition associating hypothalamic hamartoma, postaxial or central polydactyly, anal atresia and bifid epiglottis"
      explanation: >-
        Establishes hypothalamic hamartoma as a defining anomaly of the
        syndrome this node's disruption produces.
  evidence:
  - reference: PMID:10375510
    reference_title: "Gli proteins encode context-dependent positive and negative functions: implications for development and disease."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "provide a molecular basis for the human Polydactyly type A and Pallister-Hall Syndrome phenotypes, derived from the deregulated production of C-terminally truncated GLI3 proteins"
    explanation: "Truncated GLI3 repressor disrupts multiple developmental programs including hypothalamic development."
  - reference: PMID:20301638
    reference_title: "GLI3-Related Pallister-Hall Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Individuals with GLI3-PHS can have pituitary insufficiency and may die as neonates from undiagnosed and untreated adrenal insufficiency."
    explanation: "Hypothalamic hamartoma disrupts hypothalamic-pituitary signaling, causing pituitary insufficiency and potentially fatal adrenal insufficiency."
- name: Posterior Limb Patterning Disruption
  description: >
    Constitutive GLI3 repressor activity disrupts Hedgehog-dependent limb
    patterning, causing postaxial or central polydactyly. This is distinct
    from the preaxial polydactyly seen in GCPS, where GLI3 haploinsufficiency
    (reduced activator) rather than constitutive repressor drives the phenotype.
  genes:
  - preferred_term: GLI3
    term:
      id: hgnc:4319
      label: GLI3
  biological_processes:
  - preferred_term: Embryonic Limb Morphogenesis
    term:
      id: GO:0030326
      label: embryonic limb morphogenesis
  evidence:
  - reference: PMID:10375510
    reference_title: "Gli proteins encode context-dependent positive and negative functions: implications for development and disease."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "provide a molecular basis for the human Polydactyly type A and Pallister-Hall Syndrome phenotypes, derived from the deregulated production of C-terminally truncated GLI3 proteins"
    explanation: "Truncated GLI3 directly causes the polydactyly phenotype in PHS."
  downstream:
  - target: Postaxial Polydactyly
    description: >-
      Disrupted anterior-posterior patterning of the limb bud produces the
      postaxial or mesoaxial extra digits of this syndrome.
    evidence:
    - reference: PMID:24736735
      reference_title: "New insights into genotype-phenotype correlation for GLI3 mutations."
      supports: SUPPORT
      snippet: "postaxial or central polydactyly, anal atresia and bifid epiglottis"
      explanation: >-
        Names the polydactyly pattern this limb-patterning node produces.
- name: Hypothalamic-Pituitary Axis Disruption
  description: >
    The hypothalamic hamartoma disrupts normal hypothalamic-pituitary axis
    signaling, producing a spectrum of endocrine insufficiency ranging from
    isolated growth hormone deficiency to panhypopituitarism. Adrenal
    insufficiency (secondary to ACTH deficiency) is a potentially lethal
    complication in neonates and infants that requires urgent evaluation and
    cortisol replacement before or alongside other endocrine workup. Precocious
    puberty may result from ectopic GnRH secretion by the hamartoma.
  biological_processes:
  - preferred_term: Pituitary gland development
    term:
      id: GO:0021983
      label: pituitary gland development
  evidence:
  - reference: PMID:20301638
    reference_title: "GLI3-Related Pallister-Hall Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Individuals with GLI3-PHS can have pituitary insufficiency and may die as neonates from undiagnosed and untreated adrenal insufficiency."
    explanation: >-
      GeneReviews explicitly documents pituitary insufficiency as a complication
      and adrenal crisis as a potentially lethal outcome in untreated neonates.
  downstream:
  - target: Hypopituitarism
    description: >-
      Loss of normal hypothalamic input to the pituitary produces a spectrum of
      anterior pituitary hormone deficiency.
    evidence:
    - reference: PMID:20301638
      reference_title: "GLI3-Related Pallister-Hall Syndrome."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Individuals with GLI3-PHS can have pituitary insufficiency and may die as neonates from undiagnosed and untreated adrenal insufficiency."
      explanation: >-
        Documents pituitary insufficiency as a complication of the axis
        disruption this node models.
  - target: Adrenal Insufficiency
    description: >-
      ACTH deficiency within that pituitary insufficiency causes secondary
      adrenal insufficiency, the potentially lethal neonatal complication.
    evidence:
    - reference: PMID:20301638
      reference_title: "GLI3-Related Pallister-Hall Syndrome."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Individuals with GLI3-PHS can have pituitary insufficiency and may die as neonates from undiagnosed and untreated adrenal insufficiency."
      explanation: >-
        Names untreated adrenal insufficiency as a cause of neonatal death in
        this syndrome, downstream of the same axis disruption.
phenotypes:
- name: Hypothalamic Hamartoma
  description: >
    Non-neoplastic malformation of the hypothalamus, often detected
    on brain MRI. May cause precocious puberty through GnRH secretion
    or gelastic seizures. A hallmark feature distinguishing PHS from
    GCPS.
  phenotype_term:
    preferred_term: Hypothalamic hamartoma
    term:
      id: HP:0002444
      label: Hypothalamic hamartoma
  evidence:
  - reference: PMID:24736735
    reference_title: "New insights into genotype-phenotype correlation for GLI3 mutations."
    supports: SUPPORT
    snippet: "PHS was first described as a lethal condition associating hypothalamic hamartoma, postaxial or central polydactyly, anal atresia and bifid epiglottis"
    explanation: "Hypothalamic hamartoma is a cardinal feature of PHS since original description."
  sequelae:
  - target: Gelastic Seizures
    description: >-
      The hamartoma is itself the seizure generator: its interneuron-like
      neurons fire spontaneously, so the gelastic seizures arise within the
      lesion rather than in cortex.
    evidence:
    - reference: PMID:28591478
      reference_title: "Hypothalamic hamartoma: Neuropathology and epileptogenesis."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Hypothalamic hamartomas (HHs) are congenital malformations of the ventral hypothalamus resulting in treatment-resistant epilepsy and are intrinsically epileptogenic for the gelastic seizures that are the hallmark symptom of this disorder."
      explanation: >-
        States that the hamartoma is intrinsically epileptogenic for gelastic
        seizures, which is exactly the step this edge asserts.
  - target: Central Precocious Puberty
    description: >-
      Ectopic GnRH secretion by the hamartoma activates the gonadal axis ahead
      of time, producing central precocious puberty.
    evidence:
    - reference: PMID:41818657
      reference_title: "International Consensus on the Evaluation and Management of Hypothalamic Hamartomas: Results From a Modified Delphi Survey."
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      snippet: "The typical initial presentation involves a combination of DRE and/or endocrine dysfunction such as precocious puberty and obesity."
      explanation: >-
        The consensus statement on hypothalamic hamartomas attributes precocious
        puberty to the lesion itself as a typical presenting feature.
- name: Postaxial Polydactyly
  description: >
    Extra digits on the postaxial (ulnar/fibular) side, in contrast
    to the preaxial polydactyly characteristic of GCPS. Central
    polydactyly (insertional) may also occur.
  phenotype_term:
    preferred_term: Postaxial hand polydactyly
    term:
      id: HP:0001162
      label: Postaxial hand polydactyly
  evidence:
  - reference: PMID:24736735
    reference_title: "New insights into genotype-phenotype correlation for GLI3 mutations."
    supports: SUPPORT
    snippet: "postaxial or central polydactyly, anal atresia and bifid epiglottis"
    explanation: "Postaxial/central polydactyly is the characteristic limb pattern in PHS."
  - reference: PMID:28224613
    reference_title: "GLI3-related polydactyly: a review."
    supports: SUPPORT
    snippet: "four separate entities; each characterized by a specific pattern of polydactyly"
    explanation: "PHS has a distinct polydactyly pattern (postaxial) from GCPS (preaxial)."
- name: Bifid Epiglottis
  description: >
    Midline cleft of the epiglottis, a distinctive feature of PHS.
    Usually does not cause significant airway compromise but is
    diagnostically important.
  phenotype_term:
    preferred_term: Bifid epiglottis
    term:
      id: HP:0010564
      label: Bifid epiglottis
  evidence:
  - reference: PMID:24736735
    reference_title: "New insights into genotype-phenotype correlation for GLI3 mutations."
    supports: SUPPORT
    snippet: "hypothalamic hamartoma, postaxial or central polydactyly, anal atresia and bifid epiglottis"
    explanation: "Bifid epiglottis is one of the cardinal features in the original PHS description."
- name: Anal Atresia
  description: >
    Imperforate anus, occurring in a significant proportion of PHS
    patients. Requires surgical correction in the neonatal period.
  phenotype_term:
    preferred_term: Anal atresia
    term:
      id: HP:0002023
      label: Anal atresia
  evidence:
  - reference: PMID:24736735
    reference_title: "New insights into genotype-phenotype correlation for GLI3 mutations."
    supports: SUPPORT
    snippet: "hypothalamic hamartoma, postaxial or central polydactyly, anal atresia and bifid epiglottis"
    explanation: "Anal atresia is a cardinal feature of PHS."
- name: Central Precocious Puberty
  description: >
    Ectopic GnRH secretion from hypothalamic hamartoma can trigger premature
    activation of the hypothalamic-pituitary-gonadal axis, causing central
    precocious puberty. Annual surveillance during childhood monitors for
    signs of early puberty onset.
  phenotype_term:
    preferred_term: Precocious puberty
    term:
      id: HP:0000826
      label: Precocious puberty
  evidence:
  - reference: PMID:20301638
    reference_title: "GLI3-Related Pallister-Hall Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "monitor for signs of precocious puberty"
    explanation: >-
      GeneReviews surveillance guidelines specify annual monitoring for precocious
      puberty as a complication of hypothalamic hamartoma in GLI3-PHS.
- name: Gelastic Seizures
  description: >
    Hypothalamic hamartomas are associated with focal seizures, including
    characteristic gelastic (laughing) seizures. Seizures may begin or worsen
    with use of stimulants for ADHD. Symptomatic anti-seizure medication is
    the primary management approach; surgical resection of the hamartoma is
    generally contraindicated due to procedural risk.
  phenotype_term:
    preferred_term: Focal emotional seizure with laughing
    term:
      id: HP:0010821
      label: Focal emotional seizure with laughing
  evidence:
  - reference: PMID:12773293
    reference_title: "Epilepsy and hypothalamic hamartoma: look at the hand Pallister-Hall syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "who suffered from drug resistant laughing seizures since childhood"
    explanation: >-
      Case report of a PHS patient (postaxial polydactyly + hypothalamic hamartoma)
      who presented with laughing seizures (gelastic seizures) since childhood,
      directly linking this seizure type to PHS.
  - reference: PMID:20301638
    reference_title: "GLI3-Related Pallister-Hall Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "symptomatic treatment of seizures"
    explanation: >-
      GeneReviews lists seizures as a key manifestation requiring symptomatic
      treatment in GLI3-PHS, associated with hypothalamic hamartoma.
- name: Hypopituitarism
  description: >
    Disruption of hypothalamic-pituitary signaling by the malformed
    hypothalamic tissue can cause partial or complete anterior pituitary
    insufficiency, including growth hormone deficiency and ACTH deficiency.
    Pituitary function must be assessed in all newly diagnosed individuals.
  phenotype_term:
    preferred_term: Hypopituitarism
    term:
      id: HP:0040075
      label: Hypopituitarism
  evidence:
  - reference: PMID:20301638
    reference_title: "GLI3-Related Pallister-Hall Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Individuals with GLI3-PHS can have pituitary insufficiency and may die as neonates from undiagnosed and untreated adrenal insufficiency."
    explanation: >-
      GeneReviews identifies pituitary insufficiency as an important complication
      of GLI3-PHS that can be lethal if adrenal axis involvement is missed.
- name: Adrenal Insufficiency
  description: >
    Secondary (central) adrenal insufficiency from hypothalamic-pituitary
    axis disruption. Cortisol deficiency requires urgent evaluation in all
    newly diagnosed patients, particularly neonates and infants, where
    undiagnosed adrenal crisis can be fatal. Treatment with cortisol
    replacement must be initiated promptly.
  phenotype_term:
    preferred_term: Adrenal insufficiency
    term:
      id: HP:0000846
      label: Adrenal insufficiency
  evidence:
  - reference: PMID:20301638
    reference_title: "GLI3-Related Pallister-Hall Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Individuals with GLI3-PHS can have pituitary insufficiency and may die as neonates from undiagnosed and untreated adrenal insufficiency."
    explanation: >-
      GeneReviews documents adrenal insufficiency as a potentially lethal
      complication requiring urgent evaluation and treatment.
- name: Laryngeal Cleft
  description: >
    At the severe end of the GLI3-PHS spectrum, laryngotracheal cleft can
    cause respiratory compromise and neonatal lethality. Management depends
    on the extent of the cleft and degree of respiratory impairment.
  phenotype_term:
    preferred_term: Laryngeal cleft
    term:
      id: HP:0008751
      label: Laryngeal cleft
  evidence:
  - reference: PMID:20301638
    reference_title: "GLI3-Related Pallister-Hall Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "laryngotracheal cleft with neonatal lethality at the severe end"
    explanation: >-
      GeneReviews defines the clinical spectrum of GLI3-PHS from mild
      (polydactyly, bifid epiglottis) to lethal (laryngotracheal cleft).
genetic:
- name: GLI3 Mutations (Truncating, Middle Third)
  gene_term:
    preferred_term: GLI3
    term:
      id: hgnc:4319
      label: GLI3
  association: Causative
  relationship_type: CAUSATIVE
  variant_origin: GERMLINE
  notes: >
    Frameshift and nonsense mutations in the middle third of GLI3
    (ORF nt 1998-3481) on chromosome 7p14.1 specifically cause PHS.
    These produce a truncated protein that functions as a constitutive
    repressor of Hedgehog signaling targets. This is in contrast to
    GCPS, where mutations throughout the gene cause haploinsufficiency.
    The genotype-phenotype correlation is robust across multiple
    large cohort studies.

    Positional rule for disease classification: mutations in the first
    third (nt 1-1997) or final third (nt 3482-end) of the ORF cause GCPS
    only; mutations in the middle third (nt 1998-3481) cause PHS. An
    important mechanistic requirement is that PHS-causing truncated proteins
    must escape nonsense-mediated mRNA decay (NMD) to produce the constitutive
    repressor. If NMD degrades the transcript, haploinsufficiency results and
    the phenotype shifts toward GCPS. This NMD-escape requirement explains
    why not all middle-third nonsense variants produce the PHS phenotype (e.g.,
    c.2374C>T p.Arg792Ter maps to the middle-third position but causes GCPS).

    Approximately 25% of individuals have a de novo pathogenic variant; de novo
    cases tend to be more severely affected than those with an inherited variant.
  evidence:
  - reference: PMID:15739154
    reference_title: "Molecular and clinical analyses of Greig cephalopolysyndactyly and Pallister-Hall syndromes: robust phenotype prediction from the type and position of GLI3 mutations."
    supports: SUPPORT
    snippet: "Mutations in the GLI3 zinc-finger transcription factor gene cause Greig cephalopolysyndactyly syndrome (GCPS) and Pallister-Hall syndrome (PHS), which are variable but distinct clinical entities"
    explanation: "Establishes GLI3 as causative for both GCPS and PHS as allelic disorders."
  - reference: PMID:15739154
    reference_title: "Molecular and clinical analyses of Greig cephalopolysyndactyly and Pallister-Hall syndromes: robust phenotype prediction from the type and position of GLI3 mutations."
    supports: SUPPORT
    snippet: "These results demonstrate a robust correlation of genotype and phenotype for GLI3 mutations and strongly support the hypothesis that these two allelic disorders have distinct modes of pathogenesis"
    explanation: "Robust genotype-phenotype correlation across 135-patient cohort."
  - reference: PMID:20672375
    reference_title: "Molecular analysis expands the spectrum of phenotypes associated with GLI3 mutations."
    supports: SUPPORT
    snippet: "A range of phenotypes including Greig cephalopolysyndactyly and Pallister-Hall syndromes (GCPS, PHS) are caused by pathogenic mutation of the GLI3 gene"
    explanation: "Expanded cohort confirms GLI3 as the causative gene for PHS."
  - reference: PMID:20672375
    reference_title: "Molecular analysis expands the spectrum of phenotypes associated with GLI3 mutations."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: BACKGROUND
    snippet: "Mutations in the zinc finger transcription factor encoding gene GLI3 (MIM# 165240) on chromosome 7p14.1 cause Greig cephalopolysyndactyly syndrome"
    explanation: >-
      Sources the 7p14.1 cytogenetic location asserted in this record's notes.
      The sentence sits in the paper's introduction, restating the established
      GLI3 locus rather than reporting this cohort's own result.
  - reference: PMID:24736735
    reference_title: "New insights into genotype-phenotype correlation for GLI3 mutations."
    supports: SUPPORT
    snippet: "76 cases from 55 families with either a GLI3 mutation (49 GCPS and 21 PHS), or a large deletion encompassing the GLI3 gene (6 GCPS cases)"
    explanation: "Additional large cohort confirming GLI3 genotype-phenotype correlations."
diagnosis:
- name: Clinical and Molecular Diagnosis
  description: >-
    GLI3-related Pallister-Hall syndrome is diagnosed clinically from the
    combination of hypothalamic hamartoma and mesoaxial (central) polydactyly,
    and is confirmed by identification of a heterozygous GLI3 pathogenic
    variant on molecular genetic testing. Recognition matters because
    hypothalamic hamartoma may cause hypopituitarism or gelastic seizures.
  diagnosis_term:
    preferred_term: molecular genetic testing
    term:
      id: NCIT:C19770
      label: Molecular Analysis
  evidence:
  - reference: PMID:20301638
    reference_title: "GLI3-Related Pallister-Hall Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The diagnosis of GLI3-PHS can be established in a proband with both hypothalamic hamartoma and mesoaxial polydactyly."
    explanation: >-
      GeneReviews defines the cardinal clinical diagnostic dyad for
      GLI3-related Pallister-Hall syndrome.
treatments:
- name: Surgical Correction of Polydactyly
  description: >
    Surgical removal of extra digits in early childhood for
    functional and cosmetic improvement.
  therapeutic_modality: SURGERY
  treatment_term:
    preferred_term: surgical procedure
    term:
      id: NCIT:C15329
      label: Surgical Procedure
    located_in:
      preferred_term: manus
      term:
        id: UBERON:0002398
        label: manus
- name: Anal Atresia Repair
  description: >
    Neonatal surgical correction of imperforate anus, typically
    posterior sagittal anorectoplasty (PSARP).
- name: Endocrine Management
  description: >
    Adrenal insufficiency is the first priority: cortisol deficiency must be
    evaluated urgently in all newly diagnosed patients, especially neonates,
    as untreated adrenal crisis can be fatal. Annual surveillance during
    childhood includes growth assessment (for growth hormone deficiency) and
    monitoring for signs of precocious puberty. GnRH analogs may be used if
    central precocious puberty develops. Pituitary function testing should be
    performed at baseline in all patients.
  treatment_term:
    preferred_term: endocrine hormone replacement and management
    term:
      id: NCIT:C15599
      label: Hormone Replacement Therapy
  evidence:
  - reference: PMID:20301638
    reference_title: "GLI3-Related Pallister-Hall Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Urgent treatment for endocrine abnormalities, especially cortisol deficiency"
    explanation: >-
      GeneReviews prioritizes cortisol deficiency treatment above other endocrine
      management, emphasizing the lethal risk of undiagnosed adrenal insufficiency.
- name: Anti-Seizure Medication
  description: >
    Symptomatic treatment for seizures associated with hypothalamic hamartoma,
    using standard anti-seizure medications. Stimulants prescribed for
    ADHD may exacerbate seizures and should be used with caution or avoided.
  treatment_term:
    preferred_term: Anticonvulsant Therapy
    term:
      id: NCIT:C64172
      label: Anticonvulsant Therapy
  evidence:
  - reference: PMID:20301638
    reference_title: "GLI3-Related Pallister-Hall Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "symptomatic treatment of seizures"
    explanation: >-
      GeneReviews lists symptomatic seizure treatment as a key management step
      and notes that stimulants may exacerbate seizures in GLI3-PHS.
- name: Hypothalamic Hamartoma — Watchful Waiting
  description: >
    Hypothalamic hamartomas in PHS are malformations, not neoplasms; they grow
    at the same rate as surrounding brain tissue. Biopsy or surgical resection
    is generally contraindicated because complications and the resulting need for
    lifelong hormone replacement typically outweigh any potential benefit.
    Management focuses on endocrine replacement and anti-seizure therapy rather
    than surgical intervention.
  treatment_term:
    preferred_term: supportive care
    term:
      id: NCIT:C15747
      label: Supportive Care
  evidence:
  - reference: PMID:20301638
    reference_title: "GLI3-Related Pallister-Hall Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Biopsy or resection of hypothalamic hamartoma may result in complications and lifelong need for hormone replacement."
    explanation: >-
      GeneReviews explicitly states that hamartoma biopsy or resection is
      to be avoided in typical presentations of GLI3-PHS.
datasets: []
discussions:
- discussion_id: phs_scope_sporadic_hypothalamic_hamartoma
  kind: KNOWLEDGE_GAP
  status: OPEN
  prompt: >-
    Should congenital hypothalamic hamartoma syndrome (MONDO:0009436), which
    MONDO files as the sole is_a child of this entry's term and attributes to
    SMO, be curated as a subtype of Pallister-Hall syndrome?
  attaches_to:
  - pathophysiology#Hypothalamic Development Disruption
  rationale: >
    This entry declines that placement, and MONDO:0009436's own textual
    definition is the reason. That definition closes "Though hypothalamic
    hamartomas can occur in patients with certain genetic disorders (such as
    Pallister-Hall syndrome), the majority of cases are sporadic", and its
    synonyms are the bare lesion names - hypothalamic hamartoma, hamartoma of
    the hypothalamus - plus "Pallister-Hall-like syndrome". So the concept MONDO
    describes there is predominantly sporadic hypothalamic hamartoma, of which
    germline Pallister-Hall syndrome is one minority cause. Placing it beneath
    this entry inverts that relationship, and through this term it inherits
    hereditary disease, polydactyly, syndactyly, skeletal dysplasia and
    pituitary deficiency, none of which the definition claims for the sporadic
    majority.

    The causal gene MONDO records for it is also not this entry's gene. Its OWL
    axioms assert SMO (hgnc:11119), whereas Pallister-Hall syndrome is a
    germline GLI3 disorder. In sporadic hypothalamic hamartoma, SMO has been
    implicated only as one of several Shh-pathway genes falling inside
    brain-tissue-specific large copy-number or loss-of-heterozygosity lesions,
    rather than as an individually recurrent somatic target; the recurrent
    somatic genes in that series were PRKACA and GLI3. The sporadic, somatically
    driven entity is curated in this repository as Hypothalamic Hamartoma with
    Gelastic Seizures, bound to MONDO:0019484, whose own node for the initiating
    lesion is a somatic Sonic hedgehog pathway mutation. That is where an SMO
    assertion belongs, and that entry currently names SMO in prose without a
    bound genetic record, which is the open piece of work here.
  notes: >-
    Recording rather than silently resolving this, because a future curator
    following MONDO's hierarchy will find it asserting a parentage this entry
    declines. The same shape - MONDO's is_a placement disagreeing with MONDO's
    own definition of the same term - is recorded on the Hemophilia entry for
    factor XI deficiency.

references:
- reference: PMID:20301638
  title: "GLI3-Related Pallister-Hall Syndrome."
  tags:
  - GeneReviews
  findings: []

📚

References & Deep Research

References

1

PMID:20301638

GLI3-Related Pallister-Hall Syndrome.

No top-level findings curated for this source.

Pallister-Hall Syndrome

Ask OpenScientist

OpenScientist Report

Classifications

Inheritance

Discussions and Knowledge Gaps

Pathophysiology

Pathograph

Phenotypes

Genetic Associations

Medical Actions

Diagnosis

Prevalence

Source YAML

References & Deep Research

References